131 related articles for article (PubMed ID: 32035926)
1. Evaluation of Cytotoxicity of Self-Emulsifying Formulations Containing Long-Chain Lipids Using Caco-2 Cell Model: Superior Safety Profile Compared to Medium-Chain Lipids.
Desai HH; Bu P; Shah AV; Cheng X; Serajuddin ATM
J Pharm Sci; 2020 May; 109(5):1752-1764. PubMed ID: 32035926
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
4. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
[TBL] [Abstract][Full Text] [Related]
5. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?
Lam HT; Le-Vinh B; Phan TNQ; Bernkop-Schnürch A
J Pharm Pharmacol; 2019 Feb; 71(2):156-166. PubMed ID: 30251762
[TBL] [Abstract][Full Text] [Related]
6. Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility: Formulation and dispersion testing.
Desai HH; T M Serajuddin A
Int J Pharm; 2024 Apr; 654():123953. PubMed ID: 38417725
[TBL] [Abstract][Full Text] [Related]
7. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
Anby MU; Williams HD; McIntosh M; Benameur H; Edwards GA; Pouton CW; Porter CJ
Mol Pharm; 2012 Jul; 9(7):2063-79. PubMed ID: 22656917
[TBL] [Abstract][Full Text] [Related]
8. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
9. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
10. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
12. Studying the effect of lipid chain length on the precipitation of a poorly water soluble drug from self-emulsifying drug delivery system on dispersion into aqueous medium.
Prasad D; Chauhan H; Atef E
J Pharm Pharmacol; 2013 Aug; 65(8):1134-44. PubMed ID: 23837581
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
14. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
Tanaka Y; Doi H; Katano T; Kasaoka S
Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
[TBL] [Abstract][Full Text] [Related]
15. Choice of nonionic surfactant used to formulate type IIIA self-emulsifying drug delivery systems and the physicochemical properties of the drug have a pronounced influence on the degree of drug supersaturation that develops during in vitro digestion.
Devraj R; Williams HD; Warren DB; Porter CJ; Pouton CW
J Pharm Sci; 2014 Apr; 103(4):1050-63. PubMed ID: 24470073
[TBL] [Abstract][Full Text] [Related]
16. Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations.
Gumaste SG; Serajuddin ATM
Eur J Pharm Sci; 2017 Dec; 110():134-147. PubMed ID: 28506870
[TBL] [Abstract][Full Text] [Related]
17. ESR studies on the influence of physiological dissolution and digestion media on the lipid phase characteristics of SEDDS and SEDDS pellets.
Abdalla A; Mäder K
Int J Pharm; 2009 Feb; 367(1-2):29-36. PubMed ID: 18845230
[TBL] [Abstract][Full Text] [Related]
18. Application of in vitro lipolysis for the development of oral self-emulsified delivery system of nimodipine.
Alayoubi A; Aqueel MS; Cruz CN; Ashraf M; Zidan AS
Int J Pharm; 2018 Dec; 553(1-2):441-453. PubMed ID: 30385374
[TBL] [Abstract][Full Text] [Related]
19. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
20. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
